Cargando…

Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan

This study investigated the relationship between grey matter (GM) volume and blood biomarkers, blood pressure, and obesity. We aimed to elucidate lifestyle factors that promote GM volume loss. A total of 1799 participants underwent the brain dock as a medical checkup. Data regarding blood pressure,...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Keita, Kakeda, Shingo, Nemoto, Kiyotaka, Onoda, Keiichi, Yamaguchi, Shuhei, Kobayashi, Shotai, Yamakawa, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181611/
https://www.ncbi.nlm.nih.gov/pubmed/35683364
http://dx.doi.org/10.3390/jcm11112973
_version_ 1784723818859724800
author Watanabe, Keita
Kakeda, Shingo
Nemoto, Kiyotaka
Onoda, Keiichi
Yamaguchi, Shuhei
Kobayashi, Shotai
Yamakawa, Yoshinori
author_facet Watanabe, Keita
Kakeda, Shingo
Nemoto, Kiyotaka
Onoda, Keiichi
Yamaguchi, Shuhei
Kobayashi, Shotai
Yamakawa, Yoshinori
author_sort Watanabe, Keita
collection PubMed
description This study investigated the relationship between grey matter (GM) volume and blood biomarkers, blood pressure, and obesity. We aimed to elucidate lifestyle factors that promote GM volume loss. A total of 1799 participants underwent the brain dock as a medical checkup. Data regarding blood pressure, obesity measurements, and standard blood biomarkers were obtained. Further, brain magnetic resonance imaging (MRI), including high-resolution T1-weighted imaging, was performed. We calculated the grey matter brain healthcare quotient (GM-BHQ), which represents GM volume as a deviation value. After adjusting for confounding variables, multiple regression analysis revealed that body mass index (BMI) (b = −0.28, p < 0.001), gamma-glutamyltransferase (γ-GTP) (b = −0.01, p = 0.16), and fasting blood glucose (b = −0.02, p = 0.049) were significantly correlated with GM-BHQ. Although the current cross-sectional study cannot determine a cause-and-effect relationship, elevated BMI, γ-GTP, and fasting blood glucose could promote GM volume loss.
format Online
Article
Text
id pubmed-9181611
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91816112022-06-10 Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan Watanabe, Keita Kakeda, Shingo Nemoto, Kiyotaka Onoda, Keiichi Yamaguchi, Shuhei Kobayashi, Shotai Yamakawa, Yoshinori J Clin Med Article This study investigated the relationship between grey matter (GM) volume and blood biomarkers, blood pressure, and obesity. We aimed to elucidate lifestyle factors that promote GM volume loss. A total of 1799 participants underwent the brain dock as a medical checkup. Data regarding blood pressure, obesity measurements, and standard blood biomarkers were obtained. Further, brain magnetic resonance imaging (MRI), including high-resolution T1-weighted imaging, was performed. We calculated the grey matter brain healthcare quotient (GM-BHQ), which represents GM volume as a deviation value. After adjusting for confounding variables, multiple regression analysis revealed that body mass index (BMI) (b = −0.28, p < 0.001), gamma-glutamyltransferase (γ-GTP) (b = −0.01, p = 0.16), and fasting blood glucose (b = −0.02, p = 0.049) were significantly correlated with GM-BHQ. Although the current cross-sectional study cannot determine a cause-and-effect relationship, elevated BMI, γ-GTP, and fasting blood glucose could promote GM volume loss. MDPI 2022-05-25 /pmc/articles/PMC9181611/ /pubmed/35683364 http://dx.doi.org/10.3390/jcm11112973 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Watanabe, Keita
Kakeda, Shingo
Nemoto, Kiyotaka
Onoda, Keiichi
Yamaguchi, Shuhei
Kobayashi, Shotai
Yamakawa, Yoshinori
Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_full Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_fullStr Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_full_unstemmed Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_short Effects of Obesity, Blood Pressure, and Blood Metabolic Biomarkers on Grey Matter Brain Healthcare Quotient: A Large Cohort Study of a Magnetic Resonance Imaging Brain Screening System in Japan
title_sort effects of obesity, blood pressure, and blood metabolic biomarkers on grey matter brain healthcare quotient: a large cohort study of a magnetic resonance imaging brain screening system in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181611/
https://www.ncbi.nlm.nih.gov/pubmed/35683364
http://dx.doi.org/10.3390/jcm11112973
work_keys_str_mv AT watanabekeita effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT kakedashingo effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT nemotokiyotaka effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT onodakeiichi effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT yamaguchishuhei effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT kobayashishotai effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan
AT yamakawayoshinori effectsofobesitybloodpressureandbloodmetabolicbiomarkersongreymatterbrainhealthcarequotientalargecohortstudyofamagneticresonanceimagingbrainscreeningsysteminjapan